Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand.

PubWeight™: 2.83‹?› | Rank: Top 1%

🔗 View Article (PMC 190613)

Published in J Virol on September 01, 1996

Authors

J K Carr1, M O Salminen, C Koch, D Gotte, A W Artenstein, P A Hegerich, D St Louis, D S Burke, F E McCutchan

Author Affiliations

1: Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland 20850, USA. jcarr@hiv.hjf.org

Articles citing this

The challenge of HIV-1 subtype diversity. N Engl J Med (2008) 3.88

The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82

Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol (2000) 3.70

A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65

A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol (2000) 3.23

Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol (2000) 2.95

Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol (1999) 2.90

Pervasive genomic recombination of HIV-1 in vivo. Genetics (2004) 2.79

Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J Clin Microbiol (1999) 2.68

HIV sequence databases. AIDS Rev (2003) 2.20

Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. J Virol (2005) 1.98

Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J Virol (1997) 1.90

Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol (1997) 1.82

Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol (2002) 1.80

HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS (2009) 1.72

The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology (2010) 1.69

Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization. J Virol (1997) 1.68

Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities. J Virol (2000) 1.67

HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis (2009) 1.64

Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol (1997) 1.62

Identification of new CRF51_01B in Singapore using full genome analysis of three HIV type 1 isolates. AIDS Res Hum Retroviruses (2011) 1.50

Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe. J Virol (1997) 1.48

The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s. AIDS (2013) 1.48

Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J Virol (1997) 1.45

Direct demonstration of retroviral recombination in a rhesus monkey. J Virol (1997) 1.41

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate. PLoS One (2010) 1.41

Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro. J Virol (1998) 1.39

The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Retrovirology (2006) 1.33

In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms. J Virol (2002) 1.27

Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. J Virol (1998) 1.27

Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. J Virol (2000) 1.26

An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I). J Virol (1998) 1.26

Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1. J Virol (2013) 1.24

Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations. J Virol (1999) 1.23

Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol (1999) 1.22

Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon. J Virol (1999) 1.18

Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil. Emerg Infect Dis (1999) 1.12

Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR. J Virol (1997) 1.07

Seroincidence of recent human immunodeficiency virus type 1 infections in China. Clin Vaccine Immunol (2007) 1.06

Genetic recombination between human immunodeficiency virus type 1 (HIV-1) and HIV-2, two distinct human lentiviruses. J Virol (2007) 1.00

The rapid spread of recombinants during a natural in vitro infection with two human immunodeficiency virus type 1 strains. J Virol (1997) 1.00

The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways. J Virol (2010) 0.99

Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon. AIDS Res Hum Retroviruses (2010) 0.99

Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies. J Virol (2014) 0.96

Human immunodeficiency virus type 1 intersubtype (B/E) recombination in a superinfected chimpanzee. J Virol (1997) 0.92

First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina. Retrovirology (2006) 0.91

Elevated hypermutation levels in HIV-1 natural viral suppressors. Virology (2013) 0.88

Origin and epidemiological history of HIV-1 CRF14_BG. PLoS One (2011) 0.87

Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune Defic Syndr (2013) 0.86

Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies. J Virol (2000) 0.86

Impact of Tat Genetic Variation on HIV-1 Disease. Adv Virol (2012) 0.85

HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda. Metab Brain Dis (2014) 0.82

Determination of human immunodeficiency virus type 1 subtypes in Taiwan by vpu gene analysis. J Clin Microbiol (2000) 0.79

High Degree of HIV-1 Group M (HIV-1M) Genetic Diversity within Circulating Recombinant Forms: Insight into the Early Events of HIV-1M Evolution. J Virol (2015) 0.78

High genetic variability of HIV-1 in female sex workers from Argentina. Retrovirology (2007) 0.78

Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins. J Virol (2016) 0.76

Primate immunodeficiency virus classification and nomenclature: Review. Infect Genet Evol (2016) 0.75

Viral evolution and epidemiology. Curr Opin Infect Dis (1997) 0.75

Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations. PLoS One (2017) 0.75

Identification of a novel HIV-1 intra-circulating recombinant form 01_AE in China: a descendant of the previously identified CRF01_AE transmission clusters 1 and 6. Sci China Life Sci (2015) 0.75

Articles cited by this

Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol (1981) 67.56

Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79

A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature (1986) 10.76

Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol (1994) 8.98

Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc Natl Acad Sci U S A (1989) 8.13

NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol (1993) 7.42

Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses (1995) 7.12

HIV-1 tat trans-activation requires the loop sequence within tar. Nature (1988) 6.87

Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci U S A (1990) 6.66

Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell (1989) 6.28

Regulation of human immunodeficiency virus env expression by the rev gene product. J Virol (1989) 5.79

Recombination in HIV-1. Nature (1995) 5.72

Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature (1989) 4.96

A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev (1990) 4.96

Recombination in AIDS viruses. J Mol Evol (1995) 3.94

HIV-1 Tat protein trans-activates transcription in vitro. Cell (1990) 3.57

The epidemiology of HIV infection and AIDS in Thailand. AIDS (1991) 3.57

Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS (1993) 3.52

Detection of diverse HIV-1 genetic subtypes in the USA. Lancet (1995) 3.41

The HIV-1 Tat protein: an RNA sequence-specific processivity factor? Cell (1990) 3.28

High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures. J Virol (1978) 2.96

Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol (1990) 2.66

Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses (1992) 2.52

Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48

Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology (1995) 2.38

The molecular epidemiology of HIV in Asia. AIDS (1994) 2.37

Homologous recombination of copackaged retrovirus RNAs during reverse transcription. J Virol (1992) 2.29

Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic. AIDS Res Hum Retroviruses (1993) 2.22

Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. Virology (1995) 2.07

Genotypic subtypes of HIV-1 in Cameroon. AIDS (1994) 1.89

The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials. AIDS (1995) 1.69

Activation of HIV transcription by Tat. Curr Opin Genet Dev (1992) 1.57

Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J Virol (1994) 1.40

Genetic and phylogenetic analysis of env subtypes G and H in central Africa. AIDS Res Hum Retroviruses (1994) 1.34

A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization. Virus Genes (1989) 1.33

Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E. AIDS (1995) 1.13

Wide distribution of two subtypes of HIV-1 in Thailand. AIDS Res Hum Retroviruses (1992) 1.12

Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture. The Walter Reed Retroviral Research Group. J Acquir Immune Defic Syndr (1990) 1.11

Correlates of HIV-1 seropositivity among young men in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.07

Molecular characterization of HIV-1 isolated from a serum collected in 1976: nucleotide sequence comparison to recent isolates and generation of hybrid HIV. AIDS Res Hum Retroviruses (1989) 1.03

Multiple introductions of HIV-1 subtype E into the western hemisphere. Lancet (1995) 1.01

A comparison of regulatory features in primate lentiviruses. AIDS Res Hum Retroviruses (1992) 0.98

Animal virus pseudotypes. Prog Med Virol (1979) 0.96

Sequences and phylogenetic analysis of the nef gene from Thai subjects harboring subtype E HIV-1. AIDS Res Hum Retroviruses (1996) 0.83

Articles by these authors

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med (1988) 9.21

Computational modelling of visual attention. Nat Rev Neurosci (2001) 9.06

Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science (1993) 8.49

Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med (1977) 8.24

Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses (1995) 7.12

Invariant visual representation by single neurons in the human brain. Nature (2005) 6.41

The highly irregular firing of cortical cells is inconsistent with temporal integration of random EPSPs. J Neurosci (1993) 5.77

Recombination in HIV-1. Nature (1995) 5.72

Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science (2000) 5.57

Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg (1987) 5.53

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis (1996) 5.14

A saliency-based search mechanism for overt and covert shifts of visual attention. Vision Res (2000) 5.11

A direct quantitative relationship between the functional properties of human and macaque V5. Nat Neurosci (2000) 4.85

Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79

Shifts in selective visual attention: towards the underlying neural circuitry. Hum Neurobiol (1985) 4.78

Etiology of interepidemic periods of mosquito-borne disease. Proc Natl Acad Sci U S A (2000) 4.75

Are we aware of neural activity in primary visual cortex? Nature (1995) 4.74

Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg (1988) 4.65

Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA (1996) 4.50

Cellular factors couple recombination with growth phase: characterization of a new component in the lambda site-specific recombination pathway. Cell (1987) 3.94

Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS (1993) 3.52

Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis (1977) 3.51

Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol (1982) 3.44

Detection of diverse HIV-1 genetic subtypes in the USA. Lancet (1995) 3.41

Recurrent excitation in neocortical circuits. Science (1995) 3.38

Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet (1991) 3.37

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med (1993) 3.34

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet (1991) 3.26

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol (1997) 3.23

A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol (2000) 3.23

Category-specific visual responses of single neurons in the human medial temporal lobe. Nat Neurosci (2000) 3.21

Taxonomic dissection of the genus Micrococcus: Kocuria gen. nov., Nesterenkonia gen. nov., Kytococcus gen. nov., Dermacoccus gen. nov., and Micrococcus Cohn 1872 gen. emend. Int J Syst Bacteriol (1995) 3.16

G inversion in bacteriophage Mu DNA is stimulated by a site within the invertase gene and a host factor. Cell (1985) 3.00

Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J Virol (2001) 2.89

Computational vision and regularization theory. Nature (1985) 2.87

The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem (1994) 2.84

Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr (1990) 2.84

Human immunodeficiency virus infections among civilian applicants for United States military service, October 1985 to March 1986. Demographic factors associated with seropositivity. N Engl J Med (1987) 2.81

Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology (1998) 2.76

Purification and properties of the Escherichia coli host factor required for inversion of the G segment in bacteriophage Mu. J Biol Chem (1986) 2.75

Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology. AIDS Res Hum Retroviruses (1996) 2.75

Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J Clin Microbiol (1999) 2.68

Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet (2001) 2.64

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med (1987) 2.59

Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis (1985) 2.59

Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol (1996) 2.55

Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses (1992) 2.52

Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48

Synaptic background activity influences spatiotemporal integration in single pyramidal cells. Proc Natl Acad Sci U S A (1991) 2.46

An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother (1986) 2.43

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J Infect Dis (1994) 2.42

Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology (1995) 2.38

Nonlinear interactions in a dendritic tree: localization, timing, and role in information processing. Proc Natl Acad Sci U S A (1983) 2.38

Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J Virol (1994) 2.36

A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B. J Virol (1995) 2.35

Type-restricted neutralization of molecular clones of human immunodeficiency virus. Science (1988) 2.31

Comparison of discharge variability in vitro and in vivo in cat visual cortex neurons. J Neurophysiol (1996) 2.27

Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24

Constraints on cortical and thalamic projections: the no-strong-loops hypothesis. Nature (1998) 2.17

The elusive T cell receptor. Transplant Rev (1972) 2.14

Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol (1992) 2.11

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science (1996) 2.11

Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol (1982) 2.10

From stimulus encoding to feature extraction in weakly electric fish. Nature (1996) 2.09

Retinal ganglion cells: a functional interpretation of dendritic morphology. Philos Trans R Soc Lond B Biol Sci (1982) 2.08

False-positive Western blot tests for antibodies to HTLV-III. JAMA (1986) 2.07

Attention activates winner-take-all competition among visual filters. Nat Neurosci (1999) 2.04

Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg (1985) 2.04

Three-dimensional structure of the E. coli DNA-binding protein FIS. Nature (1991) 2.01

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother (1987) 2.00

Consciousness and neuroscience. Cereb Cortex (1998) 1.99

Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax (1992) 1.97

Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses (1994) 1.97

Imagery neurons in the human brain. Nature (2000) 1.95

Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol (2000) 1.95

Candidate genes for the hypoxic tumor phenotype. Cancer Res (2000) 1.94

The E.coli fis promoter is subject to stringent control and autoregulation. EMBO J (1992) 1.92

Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses (1996) 1.92

Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses (1994) 1.90

Direct measurement of human immunodeficiency virus seroconversions in a serially tested population of young adults in the United States Army, October 1985 to October 1987. Walter Reed Retrovirus Research Group. N Engl J Med (1989) 1.89

Temporal precision of spike trains in extrastriate cortex of the behaving macaque monkey. Neural Comput (1996) 1.87

Encoding of visual information by LGN bursts. J Neurophysiol (1999) 1.85

Shunting inhibition does not have a divisive effect on firing rates. Neural Comput (1997) 1.84

Eggs: conveniently packaged antibodies. Methods for purification of yolk IgG. J Immunol Methods (1981) 1.83

Microbial load of drinking water reservoir tributaries during extreme rainfall and runoff. Appl Environ Microbiol (2002) 1.81